Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 690

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 16K
Chunk 690
---
) ( 841) ( 4,316) ( 513) ( 2,363) ( 7,192)
Other segment items 3,662 ( 176) 3,486 830 633 4,949
Net (loss)/income attributable to the Company ( 157,224) 132,663 ( 24,561) 47,724 14,566 37,729
Depreciation/amortization ( 11,331) ( 762) ( 12,093) ( 158) ( 90) ( 12,341)
Additions to non-current assets (other than financial instruments and deferred tax assets) 13,442 - 13,442 2,194 1,234 16,870
Year Ended December 31, 2023
────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
Oncology/Immunology
Marketed Other
R& D Products Subtotal Ventures Unallocated Total
(in US$ ’ 000)
Revenue from external customers 364,451 164,165 528,616 309,383 - 837,999
Cost of revenue - ( 91,726) ( 91,726) ( 292,721) - ( 384,447)
Research and development expenses ( 302,001) - ( 302,001) - - ( 302,001)
Selling expenses - ( 45,505) ( 45,505) ( 7,887) - ( 53,392)
Administrative expenses ( 46,134) ( 1,832) ( 47,966) ( 5,435) ( 26,383) ( 79,784)
Interest income 802 - 802 455 34,888 36,145
Interest expense ( 279) - ( 279) ( 38) ( 442) ( 759)
Equity in earnings of an equity investee, net of tax - - - 47,295 - 47,295
Income tax (expense)/benefit ( 628) ( 159) ( 787) ( 1,201) ( 2,521) ( 4,509)
Other segment items 9,293 715 10,008 421 ( 6,196) 4,233
Net income/(loss